Home/Gen2 Neuroscience/Mark Treherne

MT

Mark Treherne

Chairman

Gen2 Neuroscience

Therapeutic Areas

Neurology Neurodegenerative Diseases

Gen2 Neuroscience Pipeline

Drug	Indication	Phase
Gen2B	Alzheimer's disease, Frontotemporal dementia, Progressive supranuclear palsy	Pre-clinical

Leadership Team at Gen2 Neuroscience

Scientific Founder and Chief Executive Officer

Chief Operating Officer

View full Gen2 Neuroscience profile